Replies to post #247859 on Avid Bioservices Inc (CDMO)

[cheynew]

I agree MH. This may not currently affect the pps, unfortunately, but it does show that management is approaching this in a manner that will be far more effective and timely than the ISTs done to date.

[Threes]

Safety in numbers hard for a JB to sabotage a trial in 166 sites worldwide.
Sweeping us under the rug with so many collaborations and KOL's, not so easy I hope.
With so many eyes on PPHM should Bavi and /or PS be the silver bullet to double efficacy in multiple indications, the genie will be out of the bottle.

Going to be hard to sweep us under the rug.